Evelin Iozsa1, Angela Caunii2,3, Monica Butnariu1,*
1University of Life Sciences “King Mihai I” from Timisoara, Timisoara, Romania
2”Victor Babes” University of Medicine and Pharmacy Timisoara, Timisoara, Romania
3Drug Data Analysis Center, Computer Chemistry and the Internet of Medical Things, “Victor Babes” University of Medicine and Pharmacy Timisoara, Timisoara, Romania
*Corresponding author: Monica Butnariu, University of Life Sciences “King Mihai I” from Timisoara, Timisoara, Romania, E-mail: [email protected]
Received Date: May 28, 2026
Published Date: June 18, 2026
Citation: Iozsa E, et al. (2026). Cyclodextrins: Development of Systems for Constant and Long-Term Release of Bioactive Compounds. Mathews J Nutr Diet. 9(1):46.
Copyrights: Iozsa E, et al. © (2026).
ABSTRACT
Cyclodextrins are cyclic oligosaccharides obtained by enzymatic degradation of starch. Due to their unique truncated cone shape, they have a hydrophobic internal cavity (which attracts fats) and a hydrophilic external surface (soluble in water). Cyclodextrins are cyclic oligomers obtained from the enzymatic degradation of starch. Cyclodextrins have a special structure composed of a hydrophobic cavity in which various poorly soluble medicinal substances can be included to form water-soluble inclusion complexes. This characteristic is at the origin of many uses of different types of cyclodextrins and they find their applicability in numerous fields: pharmaceutical and cosmetic industry, biotechnology, nanotechnology, medicine, food industry, textile industry, etc. The formulation of a cyclodextrin–drug complex depends on their chemical structure and physicochemical properties. In the pharmaceutical industry, cyclodextrins are frequently used, mainly due to their ability to increase the solubility of a poorly soluble drug substance without changing its physicochemical and biological properties.
Keywords: Drug Solubility, Cyclodextrins, Inclusion Compounds, Hydrophobic Internal Cavity, Enzymatic Degradation.